Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for Chronic Post-Stroke Non-Fluent Aphasia (CELIC-1)
NCT00821691Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Mar 2009
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amantadine in aphasia, sponsored by Centre Hospitalier Universitaire de Nice. Started Mar 2009; status: completed.
02
Drugs
amantadine
03
Conditions
aphasia
Beyond the preview
Go deeper on NCT00821691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00821691.